HIV Infection Primary
10
3
3
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (10)
Intervening With Haitian Immigrants in the U.S. to Improve HIV Outcomes
Safety and Impact of Dasatinib on Viral Persistence and Inflammation in People With HIV Under Antiretroviral Treatment
Integrated Navigation Services for Treatment Adherence, Counseling, and Research
Intervention to Enhance PrEP Persistence
The Visceral Adiposity Measurement and Observation Study
Assessing Differential Adherence to Medications and Quality of Life Among People Living With HIV and Comorbidities
Seville Cohort of People at Substantial Risk for HIV Infection on Pre-exposure Prophylaxis
Seroincidence Study Among Men Who Have Sex With Men and Transgender Women - The ImPrEP Seroincidence Study
Kinetics of HIV-RNA Decay in Seminal Plasma of Men Treated by Dolutegravir at the Time of Primary HIV Infection
Alcohol and ART Adherence in India